Literature DB >> 27908732

miR-451 inhibits cell growth, migration and angiogenesis in human osteosarcoma via down-regulating IL 6R.

Sheng-Yao Liu1, Song-Yun Deng1, Yong-Bin He1, Guo-Xin Ni2.   

Abstract

Osteosarcoma (OS) has become one of the most common primary malignant tumors in the children and adolescents with a poor prognosis owing to its high malignant and metastatic potential. Although increasing evidence indicates that miR-451 could inhibit the growth and metastasis of OS, its effect on angiogenesis in OS is still very poor. What is more, the mechanism by which miR-451 affects the OS has not been fully elucidated. In the present study, miR-451 was reduced in human osteosarcoma tissues compared with the adjacent bone tissues, and the introduction of miR-451 dramatically inhibited the growth, migration and angiogenesis in OS. Additionally, it was suggested that IL 6R is a direct target gene of miR-451. Silencing of IL 6R suppressed the growth, migration and angiogenesis of OS, which was consistent with the effect of overexpression of miR-451. In conclusion, our data demonstrate that miR-451 may function as a potential suppressor of tumor growth, migration and angiogenesis in OS via down-regulating IL 6R, suggesting a promising therapeutic avenue for managing OS.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Growth; IL-6R; Migration; Osteosarcoma; miR-451

Mesh:

Substances:

Year:  2016        PMID: 27908732     DOI: 10.1016/j.bbrc.2016.11.145

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  Downregulation of microRNA‑451 improves cell migration, invasion and tube formation in hypoxia‑treated HUVECs by targeting MIF.

Authors:  Qian Li; Yongqiu Li; Dongsen Zhang; Haifeng Gao; Xuan Gao
Journal:  Mol Med Rep       Date:  2019-06-06       Impact factor: 2.952

3.  The proliferation and invasion of osteosarcoma are inhibited by miR-101 via targetting ZEB2.

Authors:  Haopeng Lin; Xiaodong Zheng; Ting Lu; Yang Gu; Canhao Zheng; Huajie Yan
Journal:  Biosci Rep       Date:  2019-02-08       Impact factor: 3.840

4.  MiR-935 Promotes Clear Cell Renal Cell Carcinoma Migration and Invasion by Targeting IREB2.

Authors:  Fei Liu; Yuedong Chen; Bin Chen; Chunxiao Liu; Jinchun Xing
Journal:  Cancer Manag Res       Date:  2019-12-30       Impact factor: 3.989

5.  Enoxacin inhibits proliferation and invasion of human osteosarcoma cells and reduces bone tumour volume in a murine xenograft model.

Authors:  Xuwen Luo; Xuqiang Liu; Qianyuan Tao; Cong Yao; Fuqiang Wang; Zhiping Gu; Feilong Li; Xiaolong Yu; Bin Zhang; Hongxian Fan; Min Dai; Tao Nie
Journal:  Oncol Lett       Date:  2020-05-21       Impact factor: 2.967

Review 6.  Osteosarcoma Pathogenesis Leads the Way to New Target Treatments.

Authors:  Isabel Fernandes; Cecília Melo-Alvim; Raquel Lopes-Brás; Miguel Esperança-Martins; Luís Costa
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

7.  Micro-RNA-451 Reduces Proliferation of B-CPAP Human Papillary Thyroid Cancer Cells by Downregulating Expression of Activating Transcription Factor 2.

Authors:  Mei-Feng Zhang; Zhe-Wei Fei; Lei Huang
Journal:  Med Sci Monit       Date:  2021-03-16

8.  The Effect of miR-138 on the Function of Follicular Helper T Cells and the Differentiation of B Cells in Osteosarcoma.

Authors:  Zhitao Wang; Jianxiao Liang; Shanyong Jiang; Gang Zhao; Jianshu Lu; Baoen Jiang
Journal:  Comput Math Methods Med       Date:  2021-11-23       Impact factor: 2.238

Review 9.  MicroRNAs in cancer metastasis and angiogenesis.

Authors:  Weiyang Lou; Jingxing Liu; Yanjia Gao; Guansheng Zhong; Danni Chen; Jiaying Shen; Chang Bao; Liang Xu; Jie Pan; Junchi Cheng; Bisha Ding; Weimin Fan
Journal:  Oncotarget       Date:  2017-12-11

Review 10.  miR-451: A Novel Biomarker and Potential Therapeutic Target for Cancer.

Authors:  Hua Bai; Suhui Wu
Journal:  Onco Targets Ther       Date:  2019-12-16       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.